Marlow Chemicals: Raise Capital or Extend Runway?
Marlow Chemicals is a specialty chemicals business operating in India. It closed last financial year at ₹34 Cr of annual recurring revenue, growing 40% year on year.
The company burns ₹24 Cr per year on a net basis and holds ₹36 Cr of cash. Gross margin is 73%, and net revenue retention sits at 130%.
The board has been approached by a growth fund offering ₹119 Cr at a ₹476 Cr pre-money valuation. The CEO is torn: the round would fund an aggressive push into two adjacent markets, but the founders would take meaningful dilution, and one board member argues the company could reach breakeven on its existing cash instead.
The CFO wants a clear recommendation before the next board meeting.
financials
- arr cr
- 34
- cash cr
- 36
- growth pct
- 40
- gross margin pct
- 73
- net burn cr per year
- 24
- net revenue retention pct
- 130
derived hints
- net new arr
- 14
- burn multiple
- 1.71
- runway months
- 18
proposed round
- amount cr
- 119
- pre money cr
- 476
- implied dilution pct
- 20
Advise the board. Your answer should provide:
- Analysis — the financial position, computed rather than described. Show your working.
- Risks — what could go wrong on each path, and what you would monitor.
- Recommendation — a specific course of action, with the amount and terms you would accept or reject.
State any assumptions you make.
80 points, 60% to pass.
- recommendation20
- market analysis20
- risk assessment20
- financial analysis20
Reveal suggested structure
A strong answer works through, in order:
- Runway — cash ÷ monthly net burn. Here that is ₹36 Cr ÷ 2.0 = 18.0 months.
- Efficiency — burn multiple = net burn ÷ net new ARR = 24 ÷ 14 = 1.71. Below 1.5 is good; above 2 is expensive growth.
- Rule of 40 — growth % + margin %. Compare against the sector.
- Dilution — round ÷ post-money.
- Counterfactual — what breakeven requires: how much growth must be sacrificed, and is that a worse outcome than dilution?
- Decision — commit, with trigger conditions.